Log In
Print
BCIQ
Print
Print this Print this
 

525762, GSK525762

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionBromodomain inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationEpithelial cancer
Indication DetailsTreat NUT midline carcinoma (NMC)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today